Hawaii Bill: SB 463

Bill Summary

This Senate companion to HB717 establishes the Hawaii Kratom Consumer Protection Act with registration, third-party testing, labeling with alkaloid content, age restrictions, and prohibitions on dangerous compounds and synthetics—aligning with FDA guidance and proven KCPA models by enabling consumer access through transparency and safety standards, not prohibition.

Why it matters to MAHA

SB463 pairs with HB717 to advance the same evidence-based, FDA-aligned approach MAHA champions. Rather than blanket bans or surveillance, this framework trusts informed adults while protecting minors and preventing deceptive products. It demonstrates health freedom through state-level consumer protection—the opposite of federal prohibition.